Robert Cooke

Someone is pretending to be me... this is the Bob you know

[Anton Becker, MD, PhD @becker_rad]

95% of radiology departments would do well to direct 100% of their AI efforts and budget towards upgrade and maintenance of PACS, RIS and dictation software for the next 5 years

Our field is plagued by legacy software

[Intensity Therapeutics @IntensityInc]

Please read today's news release at https://t.co/mZudenLzAa about our excellent data in #sarcoma reporting increased survival and favorable safety for our drug INT230-6

[Intensity Therapeutics @IntensityInc]

Our drug INT23-6 data was just discussed and presented at #ASCO22 in live podium discussion session. Dr. Matthew Ingham from Columbia Presbyterian was on the podium to answer questions from the audience.

[Robert Cooke @realRobertCooke]

If you get a message from me… it ain’t me.

[Robert Cooke @realRobertCooke]

Charlotte my new hero.

[Mehdi Hasan @mehdirhasan]

Here is Mike Pompeo, less than a year ago, meeting with Afghanistan's new 'president,' Taliban leader Mullah Baradar, who the Trump administration had released from prison in 2018. But sure, Mike, tell us more about 'deterrence' and toughness.

[Robert Cooke @realRobertCooke]

@Gregmogel Many more things to “war” against….

[Intensity Therapeutics @IntensityInc]

It’s an honor to be named June’s “Innovator of the Month” by Sen. Murphy. We are proud to be recognized for our efforts and to represent Connecticut’s emerging biotech sector. A huge thank you to our amazing staff at Westport!

Read more: https://t.co/G5C2C1QkfZ

@ChrisMurphyCT

[Intensity Therapeutics @IntensityInc]

These strongly encouraging results in our two @ASCO presentations provide further support of INT230-6’s potential in directly killing tumors and shrinking them through abscopal effects.

#ASCO21

[Intensity Therapeutics @IntensityInc]

Major @ASCO data highlights include an estimated 62% one-year survival for INT230-6 monotherapy subjects and 88% one-year survival when combined with pembrolizumab.

#ASCO21

[Intensity Therapeutics @IntensityInc]

Use of INT230-6 alone or in combination with ipilimumab showed a median overall survival of 23.6 months in advanced sarcoma/chordoma patients compared to an expected survival of only 4 to 8 months for these patients in phase 1/2 studies.

#ASCO21

[Robert Cooke @realRobertCooke]

@IntensityInc @ASCO Wow

[Robert Cooke @realRobertCooke]

Doing great things......

[Intensity Therapeutics @IntensityInc]

We’re presenting 2 posters showcasing data that demonstrates INT230-6’s efficacy/tolerability in patients with solid tumors, as a monotherapy and in combination with checkpoint inhibitors, at the 2021 @ASCO Annual Meeting (June 4-8).

Details here: https://t.co/vrNyGjkcrv
#ASCO21

[Intensity Therapeutics @IntensityInc]

Our first #ASCO 2021 presentation describes results in patients receiving INT230-6 alone or with pembrolizumab. The second presentation is of INT230-6 in advanced #sarcoma alone and with ipilimumab.

[Intensity Therapeutics @IntensityInc]

We have partnered with The Ottawa Hospital and The Ontario Institute for Cancer Research to conduct a Phase 2 trial of INT230-6 in patients with early stage #BreastCancer.

Read more: https://t.co/5GPjYd612y

@OttawaHospital @OICR_news

[Intensity Therapeutics @IntensityInc]

INT230-6 has the potential to quickly kill tumors during the typical 4-week period from diagnosis to surgery, and thus fill a current serious void in cancer treatment.

[Robert Cooke @realRobertCooke]

@MendoLHCB @AudiophiliacMan ...and i love these panels. I can instantly “not” hear the room when I walk in. Everything is so nice and tight, and no more boomy low end.

[Robert Cooke @realRobertCooke]

Thank you @AudiophiliacMan for the tip on these acoustic panels!

[Robert Cooke @realRobertCooke]

@MendoLHCB @AudiophiliacMan It was built for my personal use. I really appreciate the interest, i am humbled! It is 2.3 watts per channel. Custom output transformers, and ridiculously overbuilt power supply. It is based on the decware schematic.

[Robert Cooke @realRobertCooke]

@OllieMeyer @AudiophiliacMan I have a friend in the picture framing business who is a ninja with mitre joints! And thank you!

[Robert Cooke @realRobertCooke]

@OllieMeyer @AudiophiliacMan I made it! :) it’s based on decware circuit.